Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | Lapatinib | 0.01 | uM | 10 | 312.50 | 120.45 | 482.00 | 495.75 | 0.9723 | 0.9726 |
| MDA-MB-231 | Linsitinib | 0.031623 | uM | 10 | 312.50 | 120.45 | 463.00 | 495.75 | 0.9339 | 0.9341 |
| MDA-MB-231 | 17-AAG | 1 | uM | 10 | 312.50 | 120.45 | 309.00 | 495.75 | 0.6233 | 0.5865 |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 660.00 | 495.75 | 1.3313 | 1.3010 | |
| MDA-MB-231 | Lapatinib | 0.1 | uM | 10 | 312.50 | 120.45 | 568.00 | 495.75 | 1.1457 | 1.1379 |
| MDA-MB-231 | Lapatinib | 0.031623 | uM | 10 | 312.50 | 120.45 | 599.00 | 495.75 | 1.2083 | 1.1942 |
| MDA-MB-231 | 0 | uM | 10 | 312.50 | 120.45 | 271.00 | 495.75 | 0.5467 | 0.4877 | |
| MDA-MB-231 | 0 | uM | 10 | 625.00 | 241.23 | 1266.00 | 1102.75 | 1.1480 | 1.1300 | |
| MDA-MB-231 | 17-AAG | 3.1623 | uM | 10 | 625.00 | 241.23 | 335.00 | 1102.75 | 0.3038 | 0.1616 |
| MDA-MB-231 | Erlotinib | 0.01 | uM | 10 | 625.00 | 241.23 | 1314.00 | 1102.75 | 1.1916 | 1.1664 |
| MDA-MB-231 | Linsitinib | 3.1623 | uM | 10 | 625.00 | 241.23 | 917.00 | 1102.75 | 0.8316 | 0.8386 |
| MDA-MB-231 | Erlotinib | 0.0033113 | uM | 10 | 625.00 | 241.23 | 1177.00 | 1102.75 | 1.0673 | 1.0603 |
| MDA-MB-231 | Lapatinib | 10 | uM | 10 | 625.00 | 241.23 | 646.00 | 1102.75 | 0.5858 | 0.5672 |
| MDA-MB-231 | Linsitinib | 0.0033113 | uM | 10 | 625.00 | 241.23 | 1263.00 | 1102.75 | 1.1453 | 1.1277 |
| MDA-MB-231 | Erlotinib | 3.1623 | uM | 10 | 625.00 | 241.23 | 1144.00 | 1102.75 | 1.0374 | 1.0338 |
| MDA-MB-231 | Lapatinib | 1 | uM | 10 | 625.00 | 241.23 | 1273.00 | 1102.75 | 1.1544 | 1.1353 |
| MDA-MB-231 | Lapatinib | 0.31623 | uM | 10 | 625.00 | 241.23 | 1537.00 | 1102.75 | 1.3938 | 1.3270 |
| MDA-MB-231 | Erlotinib | 10 | uM | 10 | 625.00 | 241.23 | 1036.00 | 1102.75 | 0.9395 | 0.9439 |
| MDA-MB-231 | Erlotinib | 19.9526 | uM | 10 | 625.00 | 241.23 | 880.00 | 1102.75 | 0.7980 | 0.8044 |
| MDA-MB-231 | 17-AAG | 0.0016596 | uM | 10 | 625.00 | 241.23 | 1419.00 | 1102.75 | 1.2868 | 1.2437 |
| MDA-MB-231 | 17-AAG | 10 | uM | 10 | 625.00 | 241.23 | 272.00 | 1102.75 | 0.2467 | 0.0563 |
| MDA-MB-231 | Linsitinib | 0.01 | uM | 10 | 625.00 | 241.23 | 1159.00 | 1102.75 | 1.0510 | 1.0459 |
| MDA-MB-231 | 0 | uM | 10 | 625.00 | 241.23 | 1377.00 | 1102.75 | 1.2487 | 1.2132 | |
| MDA-MB-231 | Linsitinib | 10 | uM | 10 | 625.00 | 241.23 | 791.00 | 1102.75 | 0.7173 | 0.7188 |
| MDA-MB-231 | Linsitinib | 19.9526 | uM | 10 | 625.00 | 241.23 | 353.00 | 1102.75 | 0.3201 | 0.1896 |